Vaccinations

FDA panel narrowly backs Pfizer RSV vaccine for older adults WASHINGTON (AP) — Federal health advisers on Tuesday narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against the respiratory illness known as RSV. AP NEWS

...

The Food and Drug Administration panel voted 7-4 on two separate questions of whether Pfizer’s data showed the vaccine was safe and effective against the respiratory virus for people 60 and older. One panelist abstained from voting. The recommendation is non-binding and the FDA will make its own decision on the vaccine in the coming months.

...

Not enough data to support multiple annual COVID boosters, U.S. CDC advisers say There is not sufficient evidence to recommend more than one COVID-19 booster shot a year for older people and those with weakened immune systems, an expert advisory group to the U.S. Centers for Disease Control and Prevention (CDC) said on Friday. Aditya Samal Reuters

...

Global COVID cases, deaths continue to drop CIDRAP

Monthly averages for new COVID-19 cases and deaths continue to decline steadily, the World Health Organization (WHO) said today in its latest pandemic update, though it cautioned that the trends are underestimated due to reduced testing and delayed reporting.

...

Analysis: Why public health officials are not panicked about bird flu A new strain of bird flu that transmits easily among wild birds has triggered an explosive spread into new corners of the globe, infecting and killing a variety of mammals species and raising fears of a pandemic more lethal than COVID-19. Julie Steenhuysen Reuters

...